Dehydroepiandrosterone levels vary according as heart failure condition in patients with idiopathic dilated cardiomyopathy

International Journal of Cardiology

Volumn 125, Issue 2, 2008, Pages 277-279

  Kawano, Hiroaki ^a   Nagayoshi, Yasuhiro ^a   Soejima, Hirofumi ^a   Tanaka, Yausaki ^a   Yamabe, Hiroshige ^a   Kinoshita, Yoshihiro ^a   Ogawa, Hisao ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Adrenal hormone; B type natriuretic peptide; Heart failure

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; HYDROCORTISONE; PRASTERONE SULFATE;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; HYDROCORTISONE BLOOD LEVEL; MALE; PRIORITY JOURNAL;

AGED; BIOLOGICAL MARKERS; CARDIOMYOPATHY, DILATED; DEHYDROEPIANDROSTERONE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED;

EID: 40849092540     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.08.115     Document Type: Article

References (14)

1. Iamberts S.W., van den Beld A.W., and van der Lely A.J. The endocrinology of aging. Science 278 (1997) 419-424
2. Alexander R.W., Schlant R.C., and Fuster V. The heart p1186. 9th ed. (1994), McGraw-Hill
3. Chon J.N., Bristow M.R., Chien K.R., et al. Report of the national heart, lung, and blood institute special emphasis panel on heart failure research. Circulation 95 (1997) 766-770
4. Cowie M.R., Struthers A.D., Wood D.A., et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 350 (1997) 1349-1353
5. Moriyama Y., Yasue H., Yoshimura M., et al. The plasma levels of dehydroepiandrosterone sulfate are decreased in patients with chronic heart failure. J Clin Endocrinol Metab 85 (2000) 1834-1840
6. David N.O., and William J.K. The adrenal cortex. In: Wilson J., Foster D., Kronenberg H., and Larsen P. (Eds). Williams textbook of endocrinology. 7th Ed (1998), Saunders, Philadelphia 517-664
7. Hornsby P.J. Biosynthesis of DHEAS by the human adrenal cortex and its age-related decline. Ann NY Acad Sci 774 (1995) 29-46
8. Miller W.L., Geller D.H., and Auchus R.J. The molecular basis of isolated 17, 20lyase deficiency. Endocr Res 24 (1998) 817-825
9. Yanagibashi K., and Hall P. Role of electron transport in the regulation of the lyase activity of C21 side-chain cleavage P-450 from porcine adrenal and testicular microsomes. J Biol Chem. 261 (1986) 8429-8433
10. Kim B.R., and Kim D.H. Influence of glutathione on the catalytic activity of reconstituted cytochrome P450 3A4. Boichem Biophys Res Commun 242 (1998) 209-212
11. Lin D., Black S.M., Nagahama Y., et al. Steroid 17alpha-hydroxylase and 17,20-lyase activities of P450c17: contributions of serine106 and P450reductase. Endocrinology 132 (1993) 2498-2506
12. Nawata H., Yanase T., Goto K., et al. Mechanism of action of anti-aging DHEA-S and replacement of DHEA-S. Mech Ageing Dev 123 (2002) 1101-1106
13. Nakamura S., Yoshimura M., Nakayama M., et al. Possible association of heart failure status with synthetic balance between aldosterone and dehydroepiandrosterone in human heart. Circulation 110 (2004) 1787-1793
14. Nawata H., Ohashi M., Haji M., et al. Atrial and brain natriuretic peptide in adrenal steroidogenesis. J Steroid Biochem Mol Biol. 40 (1991) 367-379